Trial Profile
A Phase 2 Study of ABT-751 in Subjects With Refractory Colorectal Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2014
Price :
$35
*
At a glance
- Drugs ABT 751 (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- Sponsors Abbott Healthcare
- 09 Jun 2014 New trial record